Immediate Impact
1 from Science/Nature 61 standout
Citing Papers
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
Cuproptosis: molecular mechanisms, cancer prognosis, and therapeutic applications
2025 Standout
Works of Ying Deng being referenced
PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer
2020
rs11671784 G/A variation in miR-27a decreases chemo-sensitivity of bladder cancer by decreasing miR-27a and increasing the target RUNX-1 expression
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Ying Deng | 132 | 59 | 101 | 122 | 119 | 54 | 428 | |
| Jing Zhao | 128 | 81 | 79 | 79 | 35 | 43 | 392 | |
| Hitomi Suzuki | 117 | 94 | 41 | 61 | 104 | 42 | 441 | |
| Xiao‐Qing Pei | 64 | 55 | 63 | 119 | 41 | 36 | 414 | |
| Yusuke Wada | 195 | 121 | 68 | 110 | 42 | 42 | 474 | |
| Mei Liu | 113 | 23 | 39 | 54 | 96 | 29 | 373 | |
| Jin Gu | 87 | 84 | 90 | 53 | 78 | 33 | 393 | |
| Chien‐An Liu | 64 | 165 | 77 | 58 | 176 | 32 | 458 | |
| Hui-Ju Ch’ang | 95 | 67 | 66 | 53 | 39 | 37 | 406 | |
| Joanne Chiu | 117 | 151 | 86 | 48 | 54 | 52 | 476 | |
| Jiansheng Li | 135 | 50 | 68 | 59 | 53 | 29 | 378 |
All Works
Login with ORCID to disown or claim papers
Loading papers...